English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduStudy Addresses Obstacles in HPV Self-Testing
Human papilloma virus (HPV) is a leading cause of cervical cancer in the U.S. HPV tests therefore play a central role in cervical cancer screening and prevention. Currently, test swabs are often performed in clinical settings, but there is interest in using samples that people collect themselves for HPV and other STIs. Self-collected tests have the potential to reach many people who are unwilling or unable to visit their healthcare provider due to their location, occupation, or fear of scrutiny or discrimination. However, more research is needed to establish the reliability of self-collected tests.
Researchers from LetsGetChecked Laboratories and the Permanente Medical Group compared the performance of HPV tests using 144 pairs of self-collected vaginal swabs and provider-collected swabs taken from the lining of the cervix. In addition, the scientists exposed a small number of self-collected samples to temperatures that simulate extreme seasonal fluctuations. For 15 study participants, the researchers evaluated 5 self-collected swabs to assess variability in swabs taken from the same individual. This can occur due to differences in the amount of virus in each swab. Finally, the team tested approaches to optimize the collection process, such as adjusting how long samples remained dry and providing study participants with an instructional video.
Most self-collected samples showed the same results as provider-collected samples. Discrepancies were due to smaller amounts of detectable virus in self-collected samples. The samples exposed to temperature extremes had less detectable virus than those that weren’t. Changing the time a sample remained dry didn’t influence detection. The validity of samples improved by 8.5% after people watched an instructional video.
“We performed a detailed analysis of the variables related to self-collected vaginal swabs to calculate analytical acceptability metrics, and to identify limitations in testing that can be improved to aid in modern cervical cancer screening,” said primary author Michelle Qi.
At-Home Testing for Gonorrhea and Chlamydia
In another study, researchers from the Los Angeles County Department of Public Health and LetsGetChecked Laboratories compared provider-collected and self-collected tests for Chlamydia trachomatis and Neisseria gonorrhoeae. Patients with these common infections often don’t show symptoms, making the STIs difficult to spot.
The Centers for Disease Control and Prevention suggests that self-collected samples taken from urine or swabs of the vagina, rectum, or throat are viable alternatives to samples collected by providers. Currently, however, only urine and vaginal swabs can be self-collected within clinics. The researchers were motivated to increase inclusivity and access to STI testing by exploring additional options for self-collection and home testing.
The team compared results from 164 pairs of provider-collected and home-collected rectal swabs, and 159 pairs of throat swabs. They also performed experiments on urine and vaginal swabs to assess the impact of temperature fluctuations, hand contaminants, and underfilling or overfilling of self-collected urine samples.
Compared to provider-collected samples, self-collected rectal swabs showed a positive agreement of 95.5% for C. trachomatis and 100% for N. gonorrhoeae, while self-collected throat swabs agreed with provider-collected swabs for both infections almost 100% of the time. Furthermore, there were several swabs for both pathogens that tested positive through self-collection but negative when collected by the provider. Hand contaminants had minimal effect on the tests’ performance. Results were also largely unaffected by temperature changes and improper filling of urine samples.
“Self-collected rectal and throat swabs could offer better sensitivity than those collected by physicians for detecting C. trachomatis and N. gonorrhoeae—without compromising the test’s analytical performance,” said Breland Hockman, PhD, one of the study’s authors. “Therefore, specimens of STIs collected at home offer a viable option for improving access to STI screening and could offer a non-stigmatizing approach to sexual health.”
_____________________________________________________________________
About the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo
The 2023 AACC Annual Scientific Meeting offers 5 days packed with opportunities to learn about exciting science from July 23-27 in Anaheim, California. Plenary sessions will explore microbiome-directed therapies for undernutrition, big data for practicing precision medicine, healthcare equity, cardiovascular disease in women, and promising sickle cell disease treatments.
At the Clinical Lab Expo, more than 900 exhibitors will fill the show floor of the Anaheim Convention Center in Anaheim, California, with displays of the latest diagnostic technology, including but not limited to COVID-19 testing, artificial intelligence, point-of-care, and automation.
About the Association for Diagnostics & Laboratory Medicine (ADLM) Dedicated to achieving better health through laboratory medicine, ADLM (formerly AACC) brings together more than 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, ADLM has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.myadlm.org.
